Amoxicillin Tablet, Coated
Product Images NDC 0143-9285

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 0143-9285). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Amoxicillin Tablets Usp 875 mg 1)

A dosing recommendations table for amoxicillin for adult and pediatric patients over 3 months old. It shows doses based on infection type and severity, with separate adult and child dosages, including specific notes on prepubertal children and contraindications for those under 2 years old.*

FDA Label Image

Structural Image (Amoxicillin Tablets Usp 875 mg 2)

Chemical structure diagram of amoxicillin, a beta-lactam antibiotic, showing its molecular components including a beta-lactam ring, a thiazolidine ring, and a phenol group along with a trihydrate indication (3H2O).*

FDA Label Image

Table 3 (Amoxicillin Tablets Usp 875 mg 3)

A data table showing mean pharmacokinetic parameters of Amoxicillin in healthy adults for two doses: 400 mg in 5 mL suspension and 400 mg as one chewable tablet. It presents AUC0-∞ and Cmax values with standard deviations for each form, noting administration with a light meal and peak concentrations at about 1 hour post-dose.*

FDA Label Image

Bacteria (Amoxicillin Tablets Usp 875 mg 4)

A data table listing bacteria types categorized into Gram-Positive and Gram-Negative groups. Gram-Positive bacteria include Enterococcus faecalis, Staphylococcus species, Streptococcus pneumoniae, and alpha and beta-hemolytic streptococci. Gram-Negative bacteria include Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori.*

FDA Label Image

Table 4 (Amoxicillin Tablets Usp 875 mg 5)

A table showing Helicobacter pylori eradication rates when Amoxicillin is administered as part of a triple therapy regimen. It compares evaluable analysis and intent-to-treat analysis across two studies, including confidence intervals and patient counts. Footnotes explain analysis criteria and patient inclusion details.*

FDA Label Image

Table 5 (Amoxicillin Tablets Usp 875 mg 6)

A table titled 'H. pylori Eradication Rates When Amoxicillin is Administered as Part of a Dual Therapy Regimen' showing study results with dual therapy eradication rates. It presents evaluable and intent-to-treat analyses for two studies, including confidence intervals and patient counts, with footnotes explaining inclusion criteria and analysis details.*

FDA Label Image

Table 6 (Amoxicillin Tablets Usp 875 mg 7)

Amoxicillin 875 mg coated tablets label from Hikma Pharmaceuticals USA Inc. The label shows the product is for oral use, contains 100 tablets, and is designated as a prescription drug. It includes storage instructions, dosage guidance, and warnings. The label also displays the NDC 0143-9285-01 and is labeled as dye free.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.